The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Oct 19, 2026
Snapshot (as of Oct 19, 2026): Orion Oyj (ORINY) pays a $1.80 annual dividend, yielding 1.94% at $51.10/share. Next ex-dividend date 2026-10-20. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.94%
Annual Dividend: $1.80 per share
Payout Ratio: 41.9%
Ex-Dividend Date: 2026-10-20
Sector: Healthcare
Years of Dividend History: 11
Orion Oyj dividend investors are looking at a Finnish pharmaceutical company founded in 1917, with a portfolio spanning cancer therapies like Nubeqa, Parkinson's treatments, and a broad line of Easyhaler respiratory devices. The current yield is 2.14%, with a trailing annual dividend rate of $0.86 per share. ORINY carries a beta of 0.288, meaning its price moves far less than the broader market, which suits income investors who prioritize price stability over growth. The next ex-dividend date is March 26, 2026.
Orion Oyj pays out 41.3% of earnings as dividends, a payout ratio classified as moderate (40–60%). That level leaves meaningful room to absorb earnings pressure, and the company's product mix, spanning prescription drugs, OTC healthcare, veterinary medicines, and API manufacturing, reflects demand across multiple healthcare segments. Orion Oyj dividend safety is further supported by the fact that the payout has not required earnings to be stretched thin. The main pressure point is currency: ORINY reports in euros but pays dividends in U.S. dollars, so exchange rate shifts can affect the per-share amount received by American holders.
Orion Oyj dividend history shows a CAGR of 2.7% per year from 2016 to 2025. Per-share payments grew from $0.7388 to $0.9387 over that window (2026 is a partial year and excluded from the CAGR calculation). The largest annual increase in the window was 95.5% in 2020, though the history also contains at least one year-over-year decline exceeding 5%, so growth has not been linear. Three consecutive years of increases run through the most recent complete data.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +4.3% | $0.83 (2022) | $0.94 (2025) |
| 5-Year | -10.6% | $1.64 (2020) | $0.94 (2025) |
ORINY fits dividend investors who want pharmaceutical sector exposure with low price volatility and a moderate income stream. The yield of 2.14% sits above the stock's own 5-year average of 1.92%, meaning the current entry point offers slightly more income than the historical norm. Growth is slow at 2.7% per year, and the history includes past declines, so this is not a compounding-growth dividend story. What an investor gets is a moderate (2–4%) yield backed by a 41.3% payout ratio that leaves earnings headroom, paired with a beta of 0.288 that reflects unusually low price swings for the sector.
| Payment Date | Amount per Share |
|---|---|
| 2026-03-26 | $0.5178 |
| 2025-10-16 | $0.4749 |
| 2025-04-07 | $0.4638 |
| 2024-10-16 | $0.4357 |
| 2024-03-21 | $0.4375 |
| 2023-03-23 | $0.8699 |
| 2022-03-24 | $0.8282 |
| 2021-03-26 | $0.8902 |
| 2020-05-07 | $0.8098 |
| 2020-03-26 | $0.8335 |
| Year | Total Dividends |
|---|---|
| 2026 | $0.5178 |
| 2025 | $0.9387 |
| 2024 | $0.8732 |
| 2023 | $0.8699 |
| 2022 | $0.8282 |
Project income from ORINY with the ORINY dividend calculator or track your full portfolio with the dividend tracker.